US Cystic Fibrosis Foundation supports ‘corrector’ therapy

The nonprofit drug discovery affiliate of the Cystic Fibrosis Foundation is expanding a collaboration with Vertex Pharmaceuticals Inc to develop new medicines called ‘correctors’ that aim to treat the underlying cause of cystic fibrosis.